As per the USFDA, Marksans Pharma is recalling close to six lakh bottles of diabetes drug Metformin Hydrochloride extended-release tablets in strengths of 500 mg and 750 mg in the US market
The company is recalling the product due to deviation from the current good manufacturing practices (CGMP) -- detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product